ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,672, issued on March 4, was assigned to Minovia Therapeutics Ltd. (Tirat Hacarmel, Israel).
"Mitochondrial augmentation therapy of ocular diseases" was invented by Natalie Yivgi Ohana (Haifa, Israel), Uriel Halavee (Tel Aviv, Israel), Shmuel Bukshpan (Ramat Hasharon, Israel), Noa Sher (Haifa, Israel) and Moriya Blumkin (Tel Aviv, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating ocular diseases, disorders and symptoms thereof where the disease may or may not be associa...